|
Disclaimer:
The following information is drawn from materials prepared by
candidates for promotion to full professor. It is intended to illustrate activities and materials that
might support promotion. In
using these materials, please note the following: *The
Provost (and, in some cases, the President) are the University officers
authorized to approve promotions.
All levels of review below these officers are advisory. *Only
Departments are empowered to propose promotions, and the Divisional Dean is
charged with transmitting such proposals to the Provost or returning them to
the Department. *The judgment of the Department, Dean, and Provost will
therefore be critical to assessing qualification for promotion. *Materials
considered by the Department, Dean, and Provost will also (and always)
include confidential evaluations obtained from outside the University. Materials considered by the Provost
will include the confidential evaluations of the Dean and Department, and
those considered by the Dean will include the confidential evaluations of the
Department. *Thus,
the following materials are ONLY PART of a complete proposal for promotion,
whereas promotion is based on the ENTIRE proposal. Therefore, it should not be assumed that a record
comparable to that below will necessarily result in promotion, or that a
record not comparable to that below will fail to result in promotion. The Departmental Chair is likely to
be the best source of advice as to whether promotion is feasible and, when it
is not, what additional activity may result in qualification for promotion. *This
document has been prepared as a tool for use by associate professors in the
Division of the Biological Sciences.
Other individuals who may find it informative are Department Chairmen,
Section Heads, Committee Chairmen, senior faculty and potential recruits. Its intent is to help guide
individuals and their departments as they think about promotion to Professor. This document is not intended to list
the elements that every promotion proposal will be expected to address. The following information is
presented for information purposes only and is not intended to create any
contract or agreement, and its contents are subject to addition, deletion,
and change without prior notice. |
|
|
Name: |
Anthony G. Montag, M.D. |
|
Department of Primary Appointment: |
Pathology |
|
econdary appointments: |
Surgery The College |
|
Proposed rank: |
PROFESSOR |
|
Proposed track: |
CLINICIAN-EDUCATOR |
LAY SUMMARY:
|
Dr. Montag is a surgical pathologist specializing in biopsy and
excision tissues from the musculoskeletal system and the female genital tract
and is the primary institutional reference person for both these areas. He sees on average over 3500 cases a
year. He is actively involved
with both the Gynecologic Oncology service, participating in the
multi-institutional Gynecologic Oncology Group, and the Orthopaedic Oncology
service, participating in the Connective Tissue Oncology Society. He is a regional consultant for both
these organ systems. Dr. Montag participates in a number of medical school and
graduate courses, including the summer MSTP histology course, which he
directs, and the histology segment of the medical school anatomy course,
which he helps to organize.
He lectures on the musculoskeletal and gynecologic systems in the
Clinical Pathophysiology and Therapy course, and on tumors in the
Introduction to Cellular Pathology Course. He also lectures in the Graduate Cancer Biology
Course. He is the director of
the annual University of Chicago CME course in surgical pathology, and has
lectured in this and other national review courses. He is the director of a course on Frozen sections
presented at the annual meeting of the U.S. Canadian Academy of Pathology. He teaches general surgical
pathology and his subspecialty areas to rotating senior medical students and
pathology residents. He also has
assisted and advised many graduate students in Pathology, Immunology,
Organismal Biology and Ecology and Evolution on the processing and evaluation
of tissues involved in their research. Administrative duties include the Scientific Directorship of the
Cancer Research Center Core Facility for Immunohistochemistry, Associate
Director of the Clinical Immunohistochemistry Laboratory, Medical School
Admissions Committee, Section Quality Assurance, Oversight of the Anatomic
Pathology computer system, Surgical Case Review Committee, Hospital
Performance Improvement Council and Hospital Medical Legal Committee. Dr. Montag’s publications in recent years have focused on
neoplasia, especially the diagnosis and tumor biology of sarcomas. Several publications have examined
the presence of estrogen receptor beta in mesenchymal tumors, and he has an
ongoing collaboration with the orthopaedic molecular oncology
laboratory. He has also
collaborated on studies with other departments on a variety of non-neoplastic
topics ranging from primate touch receptors to physiologic effects of stress |
|
Awards
and Honors: 1988 Honorary
Mellon Fellow, University of Chicago 1990 Voted
one of favorite teachers by class of 1990 1991 Voted
one of favorite teachers by class of 1991 1994
Voted
one of favorite teachers by class of 1994 2006
AOA Faculty teaching award Professional
Societies: International Academy of Pathology International Society of Gynecologic Pathologists Arthur Purdy Stout Society Sigma
Xi Chicago
Pathology Society Connective
Tissue Oncology Society International
Society of Bone and Soft Tissue Pathologists Regional
and National Committee Assignments: American
Cancer Society IL Division CIER Committee, 1988 - 2001 Gynecologic
Oncology Group Site
Pathologist, 1992 - present Ovary
Committee, 2001 – 2004 Rare
Tumor Committee, 2005-present Children's
Cancer Group, 1995 - 2002 ASCP
Check Sample Committee, 2002 - present Editorial
Committee: Archives
of Pathology and Laboratory Medicine; Sarcoma committee, 2005- Ad Hoc
Reviewer For: American
Journal of Clinical Pathology American
Journal of Pathology American
Journal of Sports Medicine
Archives of Pathology Chest Genes,
Chromosomes and Cancer Laboratory Investigation |
PRESENTATIONS
|
Invited Lectures: "Endometrial hyperplasia and carcinoma". Chicago
Osteopathic Hospital, Department of Obstetrics and Gynecology, May 1986 "The pathology of gastrin promotor/SV40 T antigen
transgenic mice" University
of Washington, Dept. of Pathology.
September 1988 "Tumor formation in a transgenic mouse model"
Northwestern University, Department of Pathology, February 1990 Faculty,
Cook County Graduate School of Medicine Medical Oncology Update Course, 1991, 1993 (Gynecology,
Soft tissue) Faculty,
Cook County Graduate School of Medicine Surgical Pathology Update Course,
1991, 1992, 1994 (Soft tissue) Invited
speaker, NIH pulmonary neuroendocrine workshop, September 1991. Montag A: Transgenic technologies. Anatomical Record 236(1):147-50;
discussion 150-1, 1993 Faculty, Osler
Institute Pathology Board Review Course, 1993, 1994 (Soft tissue) “Soft Tissue
Sarcomas”, Rush Medical School, Department of Pathology, 1995. “Bone Tumors”.
Chicago Pathology Society, April 1999. “B7-2 NOD knockout mouse model of peripheral neuropathy”,
University of Iowa, Department of Pathology, May 2000. Frozen
Section Diagn Director, Frozen Section Diagnosis: Pitfalls and Indications,
USCAP Short course, 2005-2008 Pediatric
Bone Tumors, Diagnostic Pediatric Surgical Pathology, July 2005 “Estrogen receptor in mesenchymal tumors: Is beta better?”
Rush Medical School, Department of Pathology, December 2005 “Estrogen receptor in mesenchymal tumors” Medical College
of Wisconsin, Department of Pathology, January 2006 Albert Kreutner Lectureship in Bone and Joint Disease,
Medical University of South Carolina, Department of Pathology, April 2006 Director,
“Current Issues in Pathology”, University of Chicago Department of Pathology,
November, 2001; October, 2002; November, 2003, 2004, 2005, 2006 |
PUBLISHED ABSTRACTS.
|
Abstracts presented at
scientific meetings since 2000: 1. Doss
BJ, Maslan AM, Montag AG, Waggoner S, Rotmensch J, Reeves WA, DeMay RM: Atypical glandular cells of undetermined
significance (AGUS) in postmenopausal women. Accepted for presentation at 89th Annual
Meeting, United States and Canadian Academy of Pathologists, New Orleans,
2000. Modern Pathology 13 (1 suppl): 33A, 2000 2. Albarracin
CT, Montag AG,
Recant W, Kuan SF: Mammary Paget cells and Toker cells express the same
immunophenotype of mucin and cytokeratin genes. Accepted for presentation at 89th Annual
Meeting, United States and Canadian Academy of Pathologists, New Orleans,
2000. Modern Pathology 14 (1 suppl): 59A, 2000 3. Albarracin
CT, Rizzo P, Metker C, Kuan SF, Jafri J, Carbone M, Montag AG: Identification of simian
virus 40 DNA sequences in mixed mullerian tumors of the uterus. Accepted for presentation at 89th
Annual Meeting, United States and Canadian Academy of Pathologists, New
Orleans, 2000. Modern Pathology 14 (1 suppl): 120A, 2000 4.
Yamada
S Diane, Montag
AG, Hrobowski Y, Benson D, Rinker-Schaeffer C: Expression of MKK4, a metastasis
suppressor gene, is down regulated in ovarian carcinomas. Accepted for presentation at the
Society of Gynecologic Oncologists 32nd Annual Meeting, Nashville, March 2001. 5.
Kuan
SF, Krausz T, Montag AG: Comparative immunohistochemical study on the expression of mucin
genes in vulvar Paget’s disease and skin appendages. Modern Pathology 14 (1
suppl): 69A, 2001 6.
Kuan
SF, Hart J, Montag AG: Can CK7/CK20 cytokeratin and MUC2/MUC5AC mucin
immunohistochemistry predict the primary tumor site of pseudomyxoma peritonei
in women? Modern Pathology 14 (1
suppl): 139A, 2001 7.
Anastasi
J, Montag AG,
Lewis VO, Dickstein JI, Vardiman JW and LeBeau MM: Primary large B cell
lymphoma of bone with multilobated nuclei: a study of 20 cases including cytogenetic
analysis. Modern Pathology 14 (1
suppl): 155A, 2001 8.
Montag AG, Lu J, Warren B, Doss BJ and
Greene G: Expression of estrogen receptor beta in ovarian granulosa cell
tumors. Modern Pathology 14(1
suppl): 141A, 2001 9.
Deyrup
AT, Krausz TN, Montag AG: C-Kit positivity in giant cell tumor of bone. Modern Pathology 15 (1 suppl): 13A,
2002 10.
Deyrup
AT, Haydon RC, Ishikawa A, He T-C, Montag AG: Beta-Catenin reactivity in
bone and soft tissue sarcomas: an analysis of 127 cases. Modern Pathology 15 (1 suppl): 13A,
2002 11.
Yang
XJ, Takahasi M, Tretiakova M, Khramtsov A, Montag A, The BT: Molecular profiling of
Wilms’ tumor by cDNA microarrays.
Modern Pathology 16 (1 suppl): 303A, 2003 12.
Chen
HM, Berney DM, Medenica M, Montag A, Krausz T: Pilar melanocytic tumor: a rare biphasic
neoplasm. Modern Pathology 16 (1 suppl): 89A, 2003 13.
Montag AG, Richardson MS, Tretiakova M:
Nasopharyngeal angiofibromas: consistent expression of estrogen receptor
beta. Modern Pathology 17 (1
suppl): 228A, 2004 14.
Wong
T, Krausz T, Tretiakova M, Montag AG: Expression of PPAR in liposarcoma and benign
lipomatous lesions. Modern
Pathology 17 (1 suppl): 20A, 2004 15.
Deyrup
AT, Tretiakova M, Khramtsov A, Montag AG: Estrogen receptor expression in vascular
neoplasms. Modern Pathology 17 (1
suppl): 12A, 2004 16.
Ryan
CW, Montag A,
Hayden JB, Hung AY, Samuels B, Hosenpud JR, Undevia S, Peabody TD, Skoog L:
Preoperative chemoradiotherapy for soft-tissue sarcomas (STS) using
pathologic necrosis as a primary endpoint. Presented at Connective Tissue Oncology Society, Montreal,
2004. 17.
Piotrowski
A, Tretiakova M, Montag AG: Ezrin expression in gastrointestinal stromal tumors
(GIST): A comparison with tumors of smooth muscle and nerve sheath
origin. Presented at 94th
Annual Meeting, United States and Canadian Academy of Pathologists, San
Antonio, 2005. Modern Pathology 18 (1 suppl): 20A, 2005 18.
Turkyilmaz
M, Tretiakova M, Krausz T, Lengyel E, Montag A: C-Met expression in different
types of ovarian epithelial tumors. Modern Pathology 18 (1 suppl): 207A, 2005 19.
Deyrup
AT, Unni KK, Montag AG: Malignant fibrous histiocytoma of bone revisited:
immunohistochemical analysis of 29 cases. Modern Pathology 18 (1 suppl): 13A, 2005 20.
Pytel
P, Wollmann RL, Montag AG: Histopathologic abnormalities in specimens from orthopedic
spine surgeries. Modern
Pathology 18 (1 suppl): 21A, 2005 21.
Pytel
P, Piotrowsi A, Gong C, Montag AG: Ezrin expression in syndromic and sporadic peripheral
nerve sheath tumors. Accepted for Connective Tissue Oncology Society Meeting,
Boca Raton FL, 2005 22.
Chang T, Fahey A, Khramtsov A, Chmura S, Montag AG. Phosphorlyated
H2AX Expression in Cervical Neoplasia.
Modern
Pathology 19 (1 suppl): 174A, 2006 23.
Deyrup
AT, Montag AG,
Unni KK: Sarcomas arising in Paget Disease of Bone, Still bad after all these
years: clinicopathologic analysis of 68 cases. Modern Pathology 19 (1 suppl): 10A, 2006 24.
Sattar
HA, Husain AN, Fu X, Montag A, Trtiakova M, Krausz T: The role of regulatory T-Cells
in immunologically preparing secretory endometrium for fetal implantation.
Modern Pathology 19 (1 suppl): 294A, 2006 |